Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Regulatory News (HVO)

Share Price Information for hVIVO (HVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.80
Bid: 27.50
Ask: 28.10
Change: 0.05 (0.18%)
Spread: 0.60 (2.182%)
Open: 27.95
High: 28.00
Low: 28.00
Prev. Close: 27.95
HVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD)

11 Dec 2019 07:00

RNS Number : 4281W
hVIVO plc
11 December 2019
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

hVIVO plc ("hVIVO")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

n/a

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Open Orphan Plc ("Open Orphan") (offeror)

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

06/12/2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - hVIVO plc

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

Nil

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Interests of hVIVO Directors in Open Orphan shares:

Name

No. of shares

%

Dr Mark Warne

2,543*

\* These Open Orphan shares are held in Dr Mark Warne's account with Interactive Investors Nominees Limited

 

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

11/12/2019

Contact name:

Anesh Patel (Interim Finance Director & Company Secretary)

Telephone number:

+44(0)207 148 1018

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEUROBRKNAUAAA
Date   Source Headline
9th Feb 20177:00 amRNSData from PrEP Biopharm's Ph. IIa clinical studies
5th Jan 20177:00 amRNSDirectors' Dealings
30th Dec 20167:00 amRNSChange of auditor
27th Oct 20167:00 amRNSNotification of Major Interest in Shares
12th Oct 20167:00 amRNSDirectors' Dealings
23rd Sep 20167:00 amRNSExercise of Share Options
22nd Sep 20167:00 amRNSHalf-year Report
21st Sep 20167:00 amRNSTrading Update
8th Sep 20167:00 amRNSNotification of Major Interest in Shares
2nd Sep 20167:00 amRNShVIVO Landmark Asthma Study Underway
4th Aug 20167:00 amRNSDirectors' Dealings
12th Jul 201612:45 pmRNSNotification of Major Interest in Shares
14th Jun 201612:00 pmRNSFavourable results for PrEP Biopharm's Flu Study
24th May 20167:00 amRNSDavid Norwood Lock-in Deed
23rd May 201612:00 pmRNSResult of AGM
28th Apr 20162:05 pmRNS2015 Annual Report and Financial Statements
27th Apr 20167:00 amRNSNotification of Major Interest in Shares
25th Apr 20167:00 amRNSInitial results for PrEP Biopharm's Flu study
22nd Apr 20167:00 amRNSJoint Venture Investment with the SEEK Group
21st Apr 201611:43 amRNSNotification of Major Interest in Shares
20th Apr 20167:01 amRNSBoard Changes
20th Apr 20167:00 amRNS2015 Audited Preliminary Results
14th Apr 20167:00 amRNSDirectors' Dealings
16th Mar 20169:32 amRNSNotification of Major Interest in Shares
6th Jan 20167:00 amRNSDirectors' Dealings
18th Dec 20157:00 amRNSNotification of Major Interest in Shares
17th Dec 20152:00 pmRNSNotification of Major Interest in Shares
17th Dec 20157:00 amRNSNotification of Major Interest in Shares
15th Dec 20152:00 pmRNSResult of General Meeting
30th Nov 20157:00 amRNSNotification of Major Interest in Shares
26th Nov 20157:00 amRNSConditional Placing to raise £20.5 million
2nd Nov 20157:01 amRNSTrading Update
2nd Nov 20157:00 amRNShVIVO invests in PrEP Biopharm Limited
5th Oct 20152:00 pmRNSDirectors' Dealings
24th Sep 20157:00 amRNSHalf Yearly Report
6th Jul 20157:00 amRNSDirectors' Dealings
25th Jun 20152:00 pmRNSExercise of Share Options
8th Jun 20154:35 pmRNSPrice Monitoring Extension
4th Jun 20154:40 pmRNSSecond Price Monitoring Extn
4th Jun 20154:35 pmRNSPrice Monitoring Extension
29th May 20157:00 amRNSNotification of Major Interest in Shares
26th May 201512:00 pmRNSResult of AGM
14th May 20157:00 amRNSDirector's Dealings
13th May 20157:00 amRNSExercise of Share Options
8th May 20157:00 amRNSDirector's Dealings
30th Apr 20156:26 pmRNSDirector's Dealings
24th Apr 20152:00 pmRNS2014 Annual Report and Financial Statements
21st Apr 20153:43 pmRNSAward of Share Options
16th Apr 20157:01 amRNS2014 Audited Preliminary Results
16th Apr 20157:00 amRNSConfirmation of Change of Name to hVIVO plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.